Hesnard, L.; Thériault, C.; Cahuzac, M.; Durette, C.; Vincent, K.; Hardy, M.-P.; Lanoix, J.; Lavallée, G.O.; Humeau, J.; Thibault, P.;
et al. Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens. Curr. Oncol. 2024, 31, 3099-3121.
https://doi.org/10.3390/curroncol31060236
AMA Style
Hesnard L, Thériault C, Cahuzac M, Durette C, Vincent K, Hardy M-P, Lanoix J, Lavallée GO, Humeau J, Thibault P,
et al. Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens. Current Oncology. 2024; 31(6):3099-3121.
https://doi.org/10.3390/curroncol31060236
Chicago/Turabian Style
Hesnard, Leslie, Catherine Thériault, Maxime Cahuzac, Chantal Durette, Krystel Vincent, Marie-Pierre Hardy, Joël Lanoix, Gabriel Ouellet Lavallée, Juliette Humeau, Pierre Thibault,
and et al. 2024. "Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens" Current Oncology 31, no. 6: 3099-3121.
https://doi.org/10.3390/curroncol31060236
APA Style
Hesnard, L., Thériault, C., Cahuzac, M., Durette, C., Vincent, K., Hardy, M.-P., Lanoix, J., Lavallée, G. O., Humeau, J., Thibault, P., & Perreault, C.
(2024). Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens. Current Oncology, 31(6), 3099-3121.
https://doi.org/10.3390/curroncol31060236